Nexus AG
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appoi… Read more
Nexus AG (NXU) - Net Assets
Latest net assets as of June 2025: €297.39 Million EUR
Based on the latest financial reports, Nexus AG (NXU) has net assets worth €297.39 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€478.19 Million) and total liabilities (€180.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €297.39 Million |
| % of Total Assets | 62.19% |
| Annual Growth Rate | 13.32% |
| 5-Year Change | 128.96% |
| 10-Year Change | 217.72% |
| Growth Volatility | 17.29 |
Nexus AG - Net Assets Trend (2013–2024)
This chart illustrates how Nexus AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nexus AG (2013–2024)
The table below shows the annual net assets of Nexus AG from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €282.96 Million | +9.43% |
| 2023-12-31 | €258.58 Million | +8.22% |
| 2022-12-31 | €238.95 Million | +67.80% |
| 2021-12-31 | €142.40 Million | +15.23% |
| 2020-12-31 | €123.58 Million | +7.34% |
| 2019-12-31 | €115.14 Million | +6.29% |
| 2018-12-31 | €108.33 Million | +5.16% |
| 2017-12-31 | €103.01 Million | +7.52% |
| 2016-12-31 | €95.80 Million | +7.57% |
| 2015-12-31 | €89.06 Million | +17.47% |
| 2014-12-31 | €75.81 Million | +6.04% |
| 2013-12-31 | €71.50 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nexus AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 387.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €158.49 Million | 56.76% |
| Other Components | €120.75 Million | 43.24% |
| Total Equity | €279.24 Million | 100.00% |
Nexus AG Competitors by Market Cap
The table below lists competitors of Nexus AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hypera SA
PINK:HYPMY
|
$1.06 Billion |
|
Sunonwealth Electric Machine Industry Co Ltd
TW:2421
|
$1.06 Billion |
|
Norconsult ASA
OL:NORCO
|
$1.06 Billion |
|
CPT Technology Group Co Ltd
SHE:000536
|
$1.06 Billion |
|
Fielmann Aktiengesellschaft
PINK:FLMNF
|
$1.06 Billion |
|
Caihong Display Devices Co Ltd
SHG:600707
|
$1.06 Billion |
|
Safety Insurance Group Inc
NASDAQ:SAFT
|
$1.06 Billion |
|
Dongjin Semichem Co. Ltd
KQ:005290
|
$1.06 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nexus AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 255,093,000 to 279,244,000, a change of 24,151,000 (9.5%).
- Net income of 30,815,000 contributed positively to equity growth.
- Dividend payments of 3,798,000 reduced retained earnings.
- Share repurchases of 1,491,000 reduced equity.
- New share issuances of 6,000 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €30.82 Million | +11.04% |
| Dividends Paid | €3.80 Million | -1.36% |
| Share Repurchases | €1.49 Million | -0.53% |
| Share Issuances | €6.00K | +0.0% |
| Other Changes | €-1.38 Million | -0.49% |
| Total Change | €- | 9.47% |
Book Value vs Market Value Analysis
This analysis compares Nexus AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 11.00x to 4.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €6.49 | €71.40 | x |
| 2018-12-31 | €6.84 | €71.40 | x |
| 2019-12-31 | €7.08 | €71.40 | x |
| 2020-12-31 | €7.63 | €71.40 | x |
| 2021-12-31 | €8.78 | €71.40 | x |
| 2022-12-31 | €13.61 | €71.40 | x |
| 2023-12-31 | €14.77 | €71.40 | x |
| 2024-12-31 | €16.17 | €71.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nexus AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.04%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.79%
- • Asset Turnover: 0.60x
- • Equity Multiplier: 1.57x
- Recent ROE (11.04%) is above the historical average (10.07%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 10.03% | 9.28% | 0.77x | 1.40x | €18.90K |
| 2014 | 10.79% | 9.76% | 0.78x | 1.41x | €607.50K |
| 2015 | 8.49% | 7.39% | 0.79x | 1.45x | €-1.35 Million |
| 2016 | 8.52% | 7.61% | 0.77x | 1.46x | €-1.41 Million |
| 2017 | 9.63% | 8.26% | 0.79x | 1.48x | €-379.60K |
| 2018 | 10.15% | 8.00% | 0.64x | 1.97x | €158.80K |
| 2019 | 9.72% | 7.34% | 0.71x | 1.87x | €-310.40K |
| 2020 | 12.41% | 9.15% | 0.73x | 1.86x | €2.90 Million |
| 2021 | 12.36% | 9.12% | 0.76x | 1.78x | €3.27 Million |
| 2022 | 8.23% | 9.25% | 0.61x | 1.46x | €-4.16 Million |
| 2023 | 9.42% | 9.95% | 0.59x | 1.61x | €-1.48 Million |
| 2024 | 11.04% | 11.79% | 0.60x | 1.57x | €2.89 Million |
Industry Comparison
This section compares Nexus AG's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nexus AG (NXU) | €297.39 Million | 10.03% | 0.61x | $1.06 Billion |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |